Karen Krasney
General Counsel bei CAPRICOR THERAPEUTICS, INC.
Vermögen: 136 119 $ am 31.03.2024
Profil
Karen G.
Krasney is currently the Director at Cardiovascular Research Foundation.
She also holds the positions of Executive Vice President & General Counsel at Capricor, Inc. and Secretary, Executive VP & General Counsel at Capricor Therapeutics, Inc. Ms. Krasney previously served as the Executive Vice President & General Counsel at Biosensors International Group Ltd.
from 2006 to 2010.
She has a graduate degree from the University of Southern California and an undergraduate degree from the University of California, Los Angeles.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.03.2024 | 20 047 ( 0,06% ) | 136 119 $ | 31.03.2024 |
Aktive Positionen von Karen Krasney
| Unternehmen | Position | Beginn |
|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | General Counsel | 01.01.2012 |
Cardiovascular Research Foundation
 Cardiovascular Research Foundation Miscellaneous Commercial ServicesCommercial Services The Cardiovascular Research Foundation operates as a civic and social association. The non-profit company is based in New York, NY. The company was founded by Charles A. Simonton. | Director/Board Member | - |
Capricor, Inc.
 Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a private company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | General Counsel | 01.01.2012 |
Ehemalige bekannte Positionen von Karen Krasney
| Unternehmen | Position | Ende |
|---|---|---|
| BIOSENSORS INTERNATIONAL GROUP LTD | General Counsel | 12.03.2010 |
Ausbildung von Karen Krasney
| University of Southern California | Graduate Degree |
| University of California, Los Angeles | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CAPRICOR THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Biosensors International Group Ltd.
 Biosensors International Group Ltd. Medical SpecialtiesHealth Technology Biosensors International Group Ltd. develops, manufactures, and markets medical devices for interventional cardiology and critical care procedures. It operates through the following segments: Interventional Cardiology, Critical Care, Cardiac Diagnostic, and Licensing Revenue. The company was founded in 1990 by Yoh Chie Lu and is headquartered in Singapore. | Health Technology |
Capricor, Inc.
Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a private company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Health Technology |
Cardiovascular Research Foundation
Cardiovascular Research Foundation Miscellaneous Commercial ServicesCommercial Services The Cardiovascular Research Foundation operates as a civic and social association. The non-profit company is based in New York, NY. The company was founded by Charles A. Simonton. | Commercial Services |
